$FRPT

Freshpet (FRPT) CEO sells shares from option exercise under 10b5-1 plan

Freshpet (FRPT) CEO William B. Cyr exercised 76,001 options and sold 39,664 shares on August 26, 2026, under a 10b5-1 plan. The options had a $10.23 exercise price, and shares were sold at $74.67 and $75.40. The transactions were part of a pre-arranged trading plan adopted in November 2025.

Original reporting
Published Aug 28, 2026, 8:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 8:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$FRPT
Bearish
medium confidence
Mentioned
$FRPT
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$FRPTBearishLow
01

Why it matters

The CEO's sale is modest relative to FRPT's market cap, likely causing only a short‑term price dip.

02

Market read

Insider sales are monitored by traders; this filing provides fresh data but limited trading impetus.

03

What to watch

The sale price (~$75) is well above the option strike ($10.23), indicating strong upside already realized.

Relevance 4/10Novelty 4/10Timing: post‑market on Aug 26 2026

Background

Form 4 filings disclose insider trades; a 10b5‑1 plan allows pre‑scheduled sales to avoid insider‑trading concerns.

Company-level read

Ticker impact

$FRPTBearishMedium confidence
Context

CEO William B. Cyr exercised 76,001 options at $10.23 and sold 39,664 shares for about $2.96 M on Aug 26 2026 under a 10b5‑1 plan.

Expected impact

Potential modest dip of 1‑2% in the short term.

Evidence & confidence

While the amount is relatively small for a mid‑cap, CEO sales are watched; the 10b5‑1 plan suggests pre‑planned execution, limiting surprise impact.

Market effects

Minimal; pet food sector unchanged.

U.S. market only, no broader regional effect.

Low; isolated insider transaction.

Counterpoint

The sale could be interpreted as confidence in the stock's liquidity rather than a lack of faith.

Key entities

  • William B. Cyr

    CEO and director of Freshpet, Inc.

Related articles

$CALMMed

Maine (NASDAQ:CALM) Vs The Rest Of The Perishable Food Stocks

Cal-Maine Foods (CALM) reported Q2 revenue of $552.6M, down 49.9% YoY, missing estimates by 2%. Mission Produce (AVO) reported $450M revenue, up 25.8% YoY, beating estimates. Flowers Foods (FLO) and Tyson Foods (TSN) missed estimates. Freshpet (FRPT) reported $305.6M revenue, up 15.5% YoY, beating estimates. Perishable food stocks are down 8.8% on average since earnings.

$FRPTMed

Freshpet at barclays consumer conference: rivals, margins and growth

Freshpet (FRPT) discussed growth and strategy at the Barclays Global Consumer Conference. The company noted increased competition but believes category growth benefits it. Key points include omni-channel sales, manufacturing tech, and focus on high-value customers. Freshpet reiterated 2027 targets of 49% adjusted gross margin and 20-22% adjusted EBITDA margin. Shares trade at $67.21 with a $3.23B market cap.

$FRPTHighAI 9/10

Freshpet (FRPT) Q2 2026 Earnings Call Transcript

Freshpet (FRPT) reported Q2 2026 results ahead of its guidance range, with its strongest growth rate in over a year and highest adjusted gross margin since Q1 2020. The company raised 2026 sales and adjusted EBITDA guidance. It cited 41% digital order growth to 16.7% of sales, and expects 700 rural lifestyle retail stores by year-end.